MetaCap

SOPHiA GENETICS SA Cash Flow Statement

NASDAQ: SOPHTechnologyEDP ServicesUSD

7.41+0.11 (+1.51%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

SOPHiA GENETICS SA free cash flow

In fiscal 2025, SOPHiA GENETICS SA generated -$35.9 million of operating cash flow and spent $574,000 on capital expenditures. That left free cash flow of -$36.5 million, a free-cash-flow margin of -47.2% of revenue.

Summary generated from market data by MetaCap's automated system. Methodology

SOPHiA GENETICS SA cash flow statement (annual)

SOPHiA GENETICS SA annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31
Net Income-79.00M-62.49M-78.98M-87.45M-73.67M-39.34M-33.79M
Net Income growth (YoY)———————
Stock-Based Compensation16.20M16.49M15.24M13.61M8.51M1.36M717.00K
Operating Cash Flow-35.89M-44.52M-53.22M-70.09M-57.94M-31.73M-31.68M
Capital Expenditures-574.00K-244.00K-1.49M-4.10M-2.68M-450.00K-1.35M
Investing Cash Flow-8.67M-4.75M12.97M41.97M-56.93M-24.32M-3.03M
Debt Issued34.56M13.93M00015.84M—
Debt Repaid——00-3.17M-16.53M-1.97M
Financing Cash Flow30.18M9.86M-2.82M-1.57M237.77M107.05M-1.02M
Free Cash Flow-36.47M-44.76M-54.72M-74.19M-60.62M-32.18M-33.03M

This table shows 7 annual periods of SOPHiA GENETICS SA's cash flow statement, from FY 2025 back to FY 2019, across 9 line items including net income, stock-based compensation, operating cash flow. Values in USD; B = billions, M = millions. Fiscal periods follow SOPH's reporting calendar. What is a cash flow statement?

More financial data